1Amacher DE.Serum transaminase elevations as indicators of hepatic injury following the administration of drugs[J].Regul Toxicol Pharmacol,1998;27(2):119-30.
2Larrey D.Epidemiology and individual susceptibility to adverse drug reactions affecting the liver[J].Semin Liver Dis,2002;22(2):145-55.
3Benichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting[J].J Hepatol,1990;11(2):272-6.
5Agal S,Baijal I,Pramanik S,et al.Monitoring and management of antituberculosis drug induced hepatotoxicity[J].J Gastroenterol Hepatol,2005;20(11):1745-52.
二级参考文献11
1Agal S, Baijal R, Pramanik S, et al. Monitoring and management of antituberculosis drug induced hepatotoxicity. J Gastroenterol Hepatol, 2005, 20: 1745-1752.
2Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther, 2003, 18:451-471.
3Schiano TD. Hepatotoxicity and complementary and alterative medicines. Clin Liver Dis, 2003, 7:453-473.
4Furbee RB, Barlotta KS. Hepatotoxicity associated with herbal products. ClinLab Med, 2006, 26:227-241.
5Benichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol, 1990, 11:272- 276.
6Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis, 2002, 22: 145-155.
7Bjomsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology, 2005, 42 : 481-489.
8Andrade RJ, Lucerna MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology, 2005,129:512-521.
9Navarro VJ, Senior JR. Drug related hepatotoxicity. N Engl J Med, 2006, 354:731-739.
10Danan G, Benichou C. Causality assessment of adverse reactions to drugs-Ⅰ. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol, 1993, 46: 1323-1230.
